The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayrand, S.-M.
Right arrow Articles by Green, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayrand, S.-M.
Right arrow Articles by Green, W. R.
The Journal of Immunology, 1998, 160: 39-50.
Copyright © 1998 by The American Association of Immunologists

An Alternative Translational Reading Frame Encodes an Immunodominant Retroviral CTL Determinant Expressed by an Immunodeficiency-Causing Retrovirus1

Shawn-Marie Mayrand2,*, David A. Schwarz2,{dagger} and William R. Green3,*

* Department of Microbiology and the Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03756; {dagger} Department of Biology, Universitiy of California at San Diego, San Diego, CA 92093

Recognition of virus-infected or transformed cells by CD8+ CTL requires a trimolecular complex composed of MHC class I, ß2-microglobulin, and a specific foreign peptide composed of 8 to 10 linear amino acids. The generation of such CTL epitopes has traditionally been thought to be from the primary open reading frame encoding the viral or tumor-associated proteins. In this report it is demonstrated that a viral CTL epitope can also be generated from an alternative reading frame. Using a combination of synthetic peptides and Sindbis or vaccinia expression systems, MHC class I Kd-restricted BALB/cByJ CTL directed against defective gag gene constructs of the LP-BM5 virus complex that causes murine AIDS were shown to have specificity for the antigenic peptide SYNTGRFPPL. This epitope is generated in a novel fashion from the second open reading frame (ORF2) of both the defective and ecotropic helper virus components of LP-BM5. Importantly, lysis of target cells expressing BM5 ecotropic helper, and/or defective viral gag, demonstrated that the SYNTGRFPPL epitope is generated during the course of a normal retroviral infection. Furthermore, MAIDS-resistant BALB/cByJ mice also generated secondary restimulated CTL specific for SYNTGRFPPL following in vivo priming with the LP-BM5 retroviral complex. These data suggest that retroviruses, and potentially other viruses and foreign genes, are capable of expressing T cell epitopes from alternative open reading frames. If one considers the influence of self peptides on T cell development, these "alternative reading frame-derived" peptides could provide an important additional influence on the functional T cell repertoire.




This article has been cited by other articles:


Home page
J. Virol.Home page
K. A. Green, T. Okazaki, T. Honjo, W. J. Cook, and W. R. Green
The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
J. Virol., March 1, 2008; 82(5): 2456 - 2469.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Ho and W. R. Green
Alternative Translational Products and Cryptic T Cell Epitopes: Expecting the Unexpected
J. Immunol., December 15, 2006; 177(12): 8283 - 8289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. B. Zook, M. T. Howard, G. Sinnathamby, J. F. Atkins, and L. C. Eisenlohr
Epitopes Derived by Incidental Translational Frameshifting Give Rise to a Protective CTL Response.
J. Immunol., June 1, 2006; 176(11): 6928 - 6934.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Ho and W. R. Green
Cytolytic CD8+ T Cells Directed against a Cryptic Epitope Derived from a Retroviral Alternative Reading Frame Confer Disease Protection
J. Immunol., February 15, 2006; 176(4): 2470 - 2475.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Schirmbeck, P. Riedl, N. Fissolo, F. A. Lemonnier, A. Bertoletti, and J. Reimann
Translation from Cryptic Reading Frames of DNA Vaccines Generates an Extended Repertoire of Immunogenic, MHC Class I-Restricted Epitopes
J. Immunol., April 15, 2005; 174(8): 4647 - 4656.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Gaur and W. R. Green
Role of a Cytotoxic-T-Lymphocyte Epitope-Defined, Alternative gag Open Reading Frame in the Pathogenesis of a Murine Retrovirus-Induced Immunodeficiency Syndrome
J. Virol., April 1, 2005; 79(7): 4308 - 4315.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Bain, P. Parroche, J. P. Lavergne, B. Duverger, C. Vieux, V. Dubois, F. Komurian-Pradel, C. Trepo, L. Gebuhrer, G. Paranhos-Baccala, et al.
Memory T-Cell-Mediated Immune Responses Specific to an Alternative Core Protein in Hepatitis C Virus Infection
J. Virol., October 1, 2004; 78(19): 10460 - 10469.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Cardinaud, A. Moris, M. Fevrier, P.-S. Rohrlich, L. Weiss, P. Langlade-Demoyen, F. A. Lemonnier, O. Schwartz, and A. Habel
Identification of Cryptic MHC I-restricted Epitopes Encoded by HIV-1 Alternative Reading Frames
J. Exp. Med., April 19, 2004; 199(8): 1053 - 1063.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. UMEMURA, H. NISHIMURA, T. YAJIMA, W. WAJJWALK, T. MATSUGUCHI, M. TAKAHASHI, Y. NISHIYAMA, M. MAKINO, Y. NAGAI, and Y. YOSHIKAI
Overexpression of interleukin-15 prevents the development of murine retrovirus-induced acquired immunodeficiency syndrome
FASEB J, November 1, 2002; 16(13): 1755 - 1763.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
X. Saulquin, E. Scotet, L. Trautmann, M.-A. Peyrat, F. Halary, M. Bonneville, and E. Houssaint
+1 Frameshifting as a Novel Mechanism to Generate a Cryptic Cytotoxic T Lymphocyte Epitope Derived from Human Interleukin 10
J. Exp. Med., February 4, 2002; 195(3): 353 - 358.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.